CEACAM5 and metastatic neoplasm: Whenever a splenic mass is detected by imaging (particularly in the context of a patient with previous malignancies, including CRC), it raises the suspicion of metastatic disease based on clinical history, CEA serum levels, and appearance on imaging studies, and it is also necessary to exclude the presence of other metastatic lesions by a PET-CT.